Kazunobu Futami Selected Research

Kazunobu Futami Research Topics

13	Neoplasms (Cancer) 03/2019 - 10/2006
3	Werner Syndrome (Werner's Syndrome) 01/2012 - 10/2006
2	Rothmund-Thomson Syndrome (Syndrome, Rothmund-Thomson) 05/2012 - 10/2006
2	Liver Neoplasms (Liver Cancer) 04/2010 - 06/2008
1	Inflammation (Inflammations) 11/2023
1	Cystitis 11/2023
1	Bites and Stings (Sting) 11/2023
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 11/2023
1	Pelvic Pain 11/2023
1	Breast Neoplasms (Breast Cancer) 03/2019
1	Genomic Instability 01/2014
1	Ovarian Neoplasms (Ovarian Cancer) 01/2013
1	Sclerosis 01/2012
1	Osteoporosis 01/2012
1	Diabetes Mellitus 01/2012
1	Dyslipidemias (Dyslipidemia) 01/2012
1	Cataract (Cataracts) 01/2012
1	Atherosclerosis 01/2012
1	Squamous Cell Carcinoma of Head and Neck 07/2011
1	Carcinoma (Carcinomatosis) 07/2011
1	Hepatocellular Carcinoma (Hepatoma) 04/2010
1	Carcinogenesis 05/2008

5	RecQ HelicasesIBA 01/2014 - 10/2006
3	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 10/2006
3	Small Interfering RNA (siRNA)IBA 01/2014 - 10/2007
2	Nucleotide AptamersIBA 11/2023 - 03/2019
2	Biomarkers (Surrogate Marker)IBA 03/2019 - 04/2010
2	A-Form DNA (A-DNA)IBA 03/2019 - 05/2008
2	DNA HelicasesIBA 01/2013 - 01/2012
2	Liposomes (Liposome)IBA 04/2010 - 06/2008
2	CamptothecinIBA 05/2008 - 10/2007
1	Immunologic Factors (Immunomodulators)IBA 11/2023
1	InterferonsIBA 11/2023
1	benzocycloheptapyridineIBA 03/2019
1	PlatinumIBA 01/2013
1	Insulin (Novolin)FDA Link 01/2012
1	Cisplatin (Platino)FDA LinkGeneric 07/2011
1	Proteins (Proteins, Gene)FDA Link 07/2011
1	Tumor Biomarkers (Tumor Markers)IBA 04/2010
1	PolymersIBA 06/2008
1	PolyethyleneimineIBA 06/2008
1	MutagensIBA 05/2008
1	Exonucleases (3' 5' Exonuclease)IBA 05/2008
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 10/2007
1	Bloom syndrome proteinIBA 02/2007
1	Estrogen ReceptorsIBA 02/2007
1	Etoposide (VP 16)FDA LinkGeneric 10/2006
1	Bleomycin (Blenoxane)FDA LinkGeneric 10/2006

4	Therapeutics 03/2019 - 10/2007
2	Drug Therapy (Chemotherapy) 01/2008 - 10/2007
1	Intravesical Administration 11/2023
1	Intravenous Injections 06/2008
1	Aftercare (After-Treatment) 10/2006